CARBOGEN AMCIS expands capacity for parenteral drug manufacturing
In France, on newly acquired land located 7 km from the existing site in Riom north of Clermont-Ferrand in Auvergne, construction have begun in January 2021 with a new, state-of-the-art facility dedicated to custom development and manufacturing of parenteral drug products.
This new state-of-the-art facility will allow for larger capacities to supply our customers with clinical batches for phase III clinical trials and small-scale for commercial. The handling of complex formulations will include a large range of APIs from biologics to highly potent compounds.
Operations will commence during Q1 of 2023.
Production Lines
Line 1 – liquid & lyophilized form
Vials
Line 2 – Fill & Finish
Vials, Prefilled Syringes and Cartridges
Formulation
Up to 400 Litres tank
Isolator
Filling Line
Lyophiliser
Batch Size
30k units of 2R – up to 45k
3.6k units per hour
Formats
Vials from 2 to 100R
Vials from 2 to 100R
PFS 1 to 10ml (option)
Cartridges (option)